Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A0ETLQ3
Wed, 21.12.2022
Asklepios Kliniken
Asklepios signs off on first-ever commercial paper program for EUR 500 million
Opening up new sources of debt capital
Strategic expansion of existing financing instruments
Hamburg, 21 December 2022. Asklepios Kliniken GmbH & Co. KGaA has signed off on the company's first-ever commercial paper (CP) program for EUR 500 million, thus gaining ac [ … ]
Wed, 21.12.2022
Asklepios Kliniken
Asklepios signs off on first-ever commercial paper program for EUR 500 million
Opening up new sources of debt capital
Strategic expansion of existing financing instruments
Hamburg, 21 December 2022. Asklepios Kliniken GmbH & Co. KGaA has signed off on the company's first-ever commercial paper (CP) program for EUR 500 million, thus gaining ac [ … ]
Thu, 24.11.2022
Asklepios Kliniken
Asklepios Group: Sound business performance in first nine months of 2022
Consolidated revenue amounts to EUR 3,935.4 million
Over 2.65 million patients treated
Hamburg, 24 November 2022. Asklepios Kliniken GmbH & Co. KGaA has posted a stable business performance in the first nine months of 2022. Over the coming months, the general economic si [ … ]
Thu, 24.11.2022
Asklepios Kliniken
Asklepios Group: Sound business performance in first nine months of 2022
Consolidated revenue amounts to EUR 3,935.4 million
Over 2.65 million patients treated
Hamburg, 24 November 2022. Asklepios Kliniken GmbH & Co. KGaA has posted a stable business performance in the first nine months of 2022. Over the coming months, the general economic si [ … ]
Thu, 25.08.2022
Asklepios Kliniken
Asklepios Kliniken: Stable development continues in H1 2022
Consolidated revenue amounts to EUR 2,608.9 million.
Energy prices and inflation pose new challenges for hospital market
Hamburg, 25 August 2022. Asklepios Kliniken GmbH & Co. KGaA has closed the first half of 2022 with a stable development of consolidated revenue and consolidated n [ … ]
Thu, 25.08.2022
Asklepios Kliniken
Asklepios Kliniken: Stable development continues in H1 2022
Consolidated revenue amounts to EUR 2,608.9 million.
Energy prices and inflation pose new challenges for hospital market
Hamburg, 25 August 2022. Asklepios Kliniken GmbH & Co. KGaA has closed the first half of 2022 with a stable development of consolidated revenue and consolidated n [ … ]
Wed, 25.05.2022
Asklepios Kliniken
Asklepios Group: Sound growth despite challenging environment in first quarter of 2022
Number of patients up 15.6%
Consolidated revenue of EUR 1,276.3 million
Well equipped for current uncertainties with central, standardized purchasing strategy
Hamburg, 25 May 2022. In a first quarter dominated by the war in Ukraine and the continuing effects o [ … ]
Thu, 28.04.2022
Asklepios Kliniken
Asklepios Kliniken: Stable development in 2021 financial year despite negative impact from COVID-19 pandemic
Consolidated net income (EAT) of EUR 106.3 million
Number of patients treated comes to around 3.5 million
Consistently high capital expenditure of EUR 332.6 million, own funds ratio of 72.8%
Strategic partnership with Rhön-Klinikum AG ha [ … ]
Thu, 25.11.2021
Asklepios Kliniken
Asklepios Kliniken: Stable business performance in the first nine months of 2021
About 2.4 million patients being treated
Consolidated revenue of EUR 3,818.8 million
Sharp rise in COVID-19 patients expected in hospitals
Hamburg, 25 November 2021. The business development of Asklepios Kliniken GmbH & Co. KGaA gradually stabilised in the first [ … ]
Mon, 08.11.2021
Asklepios Kliniken
Asklepios secures early refinancing of schuldschein loan agreements via exchange and increase offer
Successful extension of maturity profile through early refinancing of schuldschein maturities in 2022 and 2023
Significant interest from existing investors
Hamburg, 8 November 2021. Asklepios Kliniken GmbH & Co. KGaA has achieved early refinan [ … ]